Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Richard Pavkov"'
Autor:
Jeffry G. Weers, David E. Geller, Silvia Heuerding, Richard Malcolmson, Richard Pavkov, Paul Mastoridis, Alfred Haynes, Laurie DeBonnett, Brian Ament, Anthony Yadao
Publikováno v:
Pediatric Pulmonology. 51:1159-1167
Summary Introduction TOBI® Podhaler™ is a capsule-based drug-device combination (tobramycin inhalation powder [TIP] 28 mg capsules via unit-dose dry powder T-326 Inhaler [Podhaler™]) developed for treatment of Pseudomonas aeruginosa infection in
Autor:
Alfred, Haynes, David, Geller, Jeffry, Weers, Brian, Ament, Richard, Pavkov, Richard, Malcolmson, Laurie, Debonnett, Paul, Mastoridis, Anthony, Yadao, Silvia, Heuerding
Publikováno v:
Pediatric pulmonology. 51(11)
TOBIInspiratory flow profiles were recorded from 38 subjects aged 6-71 who had CF and varying degrees of lung function impairment. Ten of the inspiratory flow profiles were simulated in the laboratory using a custom breath simulator to determine deli
Autor:
Ilse Rietveld, Stefan Mueller, Dilraj Singh, Katrin Fiebich, Richard Pavkov, Dominik Ziegler, Juergen Dederichs, Frank Stowasser, Mukul Dalvi, Benoît Walter, Giovanni Pignatelli
Publikováno v:
Current medical research and opinion. 26(11)
To report performance characteristics and robustness of the Breezhaler device, a new capsule based dry powder inhaler (DPI) with low resistance (0.07 cm H(2)O(½)/L/min) facilitating high inspiratory flow rates. This device was developed to deliver t
Autor:
Knut Sommerer, Richard Pavkov, Dilraj Singh, Katrin Fiebich, Juergen Dederichs, Martina Schulte
Publikováno v:
C41. EMERGING PHARMACOLOGY FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE: MECHANISMS AND OUTCOMES.